drugset / Trial / NCT05033444
A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers
RandomizedSequentialQuadruple-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of different dose levels of PRV-002 in Health Volunteers
Timeline
- Start
- 2022-02-09
- Primary completion
- 2022-10-01
- Completion
- 2024-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRV-002 | Unknown | 0.133 mg/kg | — |
| Subject | PRV-002 | Unknown | 0.266 mg/kg | — |
| Subject | PRV-002 | Unknown | 0.533 mg/kg | — |